Summary of quarterly results filing for Fredun Pharmaceuticals Ltd published on 09 Feb, 2026
1. Auditor’s Note
- The auditor’s review report from R.H. Nisar & Co. for both standalone and consolidated unaudited quarterly financial results for the quarter ended 31st December 2025 contains no qualifications, concerns, or issues.
- The report states:
"Nothing has come to our attention that causes us to believe that the accompanying Statement... has not disclosed the information required... or that it contains any material misstatement."
- This is a standard unqualified review report under Ind AS 34 and SEBI Listing Regulations.
2. Financial Performance
Standalone Financial Results (₹ Lakhs)
| PARTICULARS | Q3 FY26 (31.12.2025) | Q2 FY26 (30.09.2025) | Q3 FY25 (31.12.2024) | 9M FY26 (31.12.2025) | 9M FY25 (31.12.2024) | FY25 (31.03.2025) |
|---|---|---|---|---|---|---|
| Income from Operations | ||||||
| Net Sales / Income From Operation (Net of GST) | 15,992.63 | 14,358.53 | 10,184.09 | 42,291.45 | 28,626.86 | 45,170.62 |
| Other Operating Income | 99.70 | 170.61 | 85.58 | 315.52 | 259.24 | 456.20 |
| Total income from operations (net) | 16,092.33 | 14,529.14 | 10,269.67 | 42,606.97 | 28,886.10 | 45,626.82 |
| Expenses | ||||||
| a) Cost of Material Consumed | 11,763.43 | 9,925.75 | 7,265.62 | 30,721.80 | 19,756.09 | 32,188.90 |
| b) Cost of Material Consumed for R & D | 127.64 | 118.32 | 52.25 | 321.43 | 141.16 | 209.34 |
| c) Other R & D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| d) Changes in inventories of finished goods, work-in-progress and stock in trade | (735.43) | 441.29 | (26.07) | (960.28) | 728.36 | 605.00 |
| e) Manufacturing & Service Cost | 372.21 | 366.13 | 472.72 | 1,102.25 | 1,296.57 | 1,755.54 |
| f) Finance Costs | 1,054.95 | 773.13 | 500.47 | 2,481.25 | 1,422.92 | 2,237.66 |
| g) Employees benefits expenses | 814.62 | 829.88 | 584.93 | 2,407.89 | 1,253.33 | 2,223.12 |
| h) Depreciation and amortisation expenses | 178.40 | 159.80 | 108.92 | 480.11 | 319.96 | 444.91 |
| i) Other Expenses | 1,116.26 | 614.25 | 597.42 | 2,447.64 | 1,944.80 | 3,135.27 |
| Total expenses | 14,692.08 | 13,228.55 | 9,556.26 | 39,002.09 | 26,863.19 | 42,799.74 |
| Profit / (Loss) from ordinary activities before exceptional items & tax (3-4) | 1,400.25 | 1,300.59 | 713.41 | 3,604.88 | 2,022.91 | 2,827.08 |
| Exceptional items / Prior Period Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/(Loss) from ordinary activities before tax (5-6) | 1,400.25 | 1,300.59 | 713.41 | 3,604.88 | 2,022.91 | 2,827.08 |
| Tax Expenses | 352.44 | 327.36 | 180.15 | 907.26 | 649.33 | 746.32 |
| Profit/(Loss) from continuing operations | 1,047.81 | 973.23 | 533.26 | 2,697.62 | 1,373.58 | 2,080.76 |
| Profit/(Loss) from discontinued operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Expense of discontinued operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/(Loss) from discontinued operations after tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/ (Loss) for the period | 1,047.81 | 973.23 | 533.26 | 2,697.62 | 1,373.58 | 2,080.76 |
| Other comprehensive Income | ||||||
| A (i) Items that will not be re-classified to profit/ loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (ii) Income tax relating to items that will not be reclassified to profit/ loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| B (i) Re measurement of post - employment benefit obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (34.35) |
| C (i) Items that will be re-classified to profit / loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (ii) Income tax relating to items that will be re-classified to profit / loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Comprehensive Income for the year | 1,047.81 | 973.23 | 533.26 | 2,697.62 | 1,373.58 | 2,046.41 |
Consolidated Financial Results (₹ Lakhs)
| PARTICULARS | Q3 FY26 (31.12.2025) | Q2 FY26 (30.09.2025) | Q3 FY25 (31.12.2024) | 9M FY26 (31.12.2025) | 9M FY25 (31.12.2024) | FY25 (31.03.2025) |
|---|---|---|---|---|---|---|
| Income from Operations | ||||||
| Net Sales / Income From Operation (Net of GST) | 15,992.63 | 14,358.53 | 0.00 | 42,291.45 | 0.00 | 45,170.65 |
| Other Operating Income | 99.70 | 170.62 | 0.00 | 315.53 | 0.00 | 456.20 |
| Total income from operations (net) | 16,092.33 | 14,529.15 | 0.00 | 42,606.98 | 0.00 | 45,626.85 |
| Expenses | ||||||
| a) Cost of Material Consumed | 11,763.43 | 9,925.76 | 0.00 | 30,721.81 | 0.00 | 32,188.90 |
| b) Cost of Material Consumed for R & D | 127.64 | 118.33 | 0.00 | 321.44 | 0.00 | 209.34 |
| c) Other R & D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| d) Changes in inventories of finished goods, work-in-progress and stock in trade | (735.43) | 441.28 | 0.00 | (960.29) | 0.00 | 605.00 |
| e) Manufacturing & Service Cost | 372.21 | 366.13 | 0.00 | 1,102.25 | 0.00 | 1,755.54 |
| f) Finance Costs | 1,054.95 | 773.13 | 0.00 | 2,481.25 | 0.00 | 2,237.66 |
| g) Employees benefits expenses | 814.62 | 829.88 | 0.00 | 2,407.89 | 0.00 | 2,223.12 |
| h) Depreciation and amortisation expenses | 178.40 | 189.31 | 0.00 | 509.62 | 0.00 | 503.95 |
| i) Other Expenses | 1,116.27 | 614.80 | 0.00 | 2,448.20 | 0.00 | 3,153.99 |
| Total expenses | 14,692.09 | 13,258.62 | 0.00 | 39,032.17 | 0.00 | 42,877.50 |
| Profit/(Loss) from ordinary activities before exceptional items & tax (3-4) | 1,400.24 | 1,270.53 | 0.00 | 3,574.81 | 0.00 | 2,749.35 |
| Exceptional items / Prior Period Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/(Loss) from ordinary activities before tax (5-6) | 1,400.24 | 1,270.53 | 0.00 | 3,574.81 | 0.00 | 2,749.35 |
| Tax Expenses | 352.44 | 327.36 | 0.00 | 907.26 | 0.00 | 775.42 |
| Profit/(Loss) from continuing operations | 1,047.80 | 943.17 | 0.00 | 2,667.55 | 0.00 | 1,973.93 |
| Profit/(Loss) from discontinued operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Expense of discontinued operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/(Loss) from discontinued operations after tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/ (Loss) for the period | 1,047.80 | 943.17 | 0.00 | 2,667.55 | 0.00 | 1,973.93 |
| Other comprehensive Income | ||||||
| A (i) Items that will not be re-classified to profit/ loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (ii) Income tax relating to items that will not be reclassified to profit/ loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| B (i) Re measurement of post - employment benefit obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (34.35) |
| C (i) Items that will be re-classified to profit / loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (ii) Income tax relating to items that will be re-classified to profit / loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Comprehensive Income for the year | 1,047.80 | 943.17 | 0.00 | 2,667.55 | 0.00 | 1,939.58 |
3. Detailed Notes / Management Commentary
- The results are unaudited and have been reviewed by the statutory auditors with no qualifications.
- The financials are prepared in accordance with Ind AS 34 - Interim Financial Reporting.
- No exceptional items or prior period adjustments reported for the periods presented.
- No discontinued operations or related tax expenses reported.
- Other comprehensive income is nil except for a re-measurement loss of ₹34.35 Lakhs on post-employment benefit obligations in FY25.
- No changes in accounting policies or material adjustments mentioned.
- No specific management commentary or caveats provided in the filing.
- The consolidated results include subsidiaries:
- Fredun Retail Private Limited
- One Pet Stop Private Limited
- Wagr Retail Private Limited
4. Segment Information
- No segment-wise or geographic breakdown of revenue or profit is provided in the filing.
- No segment EBIT/PBIT margins or growth rates are disclosed.
5. Capex, Projects, and Corporate Activity
- No information on capital expenditure (planned or executed) is disclosed.
- No mention of ongoing or planned projects.
- No writedowns, writebacks, impairments, or provisions reported.
- No acquisitions, disposals, divestitures, mergers, or restructuring efforts mentioned.
- No cost-cutting measures or strategic shifts disclosed.
6. Standalone vs Consolidated
- Both Standalone and Consolidated unaudited financial results for the quarter and nine months ended 31st December 2025 are provided.
- The consolidated results include the three subsidiaries mentioned above.
- The consolidated figures closely mirror the standalone figures, indicating limited impact of subsidiaries on overall financials.
- No EPS or margin percentages are provided in either standalone or consolidated results.
Summary
- Auditor’s Note: Clean review report with no qualifications.
- Financials:
- Strong growth in revenue and profit YoY and QoQ in both standalone and consolidated results.
- Total income from operations (Standalone) increased from ₹10,269.67 Lakhs in Q3 FY25 to ₹16,092.33 Lakhs in Q3 FY26.
- Profit before tax (Standalone) increased from ₹713.41 Lakhs in Q3 FY25 to ₹1,400.25 Lakhs in Q3 FY26.
- Profit after tax (Standalone) increased from ₹533.26 Lakhs in Q3 FY25 to ₹1,047.81 Lakhs in Q3 FY26.
- No exceptional items or discontinued operations.
- No segment or project disclosures.
- No capex or corporate activity details.
This completes the extraction of all relevant and actionable financial information from the filing.